Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-02 to 2024-07-24
Current total value of award: $10273.38
Description: 4565077655!XOLAIR 300 MG/2 ML SYRINGE 2ML